Clinical efficacy and safety of antifungal drugs for the treatment of Candida parapsilosis infections: a systematic review and network meta-analysis

被引：6

作者：

Qin, Jielin ^{[1
]}

Yang, Han ^{[2
]}

Shan, Zhiming ^{[3
]}

Jiang, Lingzhi ^{[4
]}

Zhang, Qingxian ^{[1
]}

机构：

[1] Zhengzhou Univ, Dept Gen Med, Dept Respirat & Intens Med, Affiliated Hosp 1, Zhengzhou 450000, Henan, Peoples R China

[2] Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Zhengzhou 450000, Henan, Peoples R China

[3] Zhengzhou Univ, Henan Childrens Hosp, Zhengzhou Childrens Hosp, Lab Dept,Childrens Hosp,Zhengzhou Children Infect, Zhengzhou 450000, Henan, Peoples R China

[4] Zhengzhou Univ, Dept Nephrol, Affiliated Hosp 1, Zhengzhou 450000, Henan, Peoples R China

来源：

JOURNAL OF MEDICAL MICROBIOLOGY | 2021年 / 70卷 / 10期

关键词：

antifungal drugs; Candida parapsilosis; clinical efficacy; meta-analysis; safety; LIPOSOMAL AMPHOTERICIN-B; BLOOD-STREAM INFECTIONS; FLUCONAZOLE; EPIDEMIOLOGY; CASPOFUNGIN; MICAFUNGIN; OUTBREAK; SURVEILLANCE; FUNGEMIA;

D O I：

10.1099/jmm.0.001434

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Antifungal drugs have already been established as an effective treatment option for Candida parapsilosis infections, but there is no universal consensus on the ideal target for clinical efficacy and safety of antifungal drugs for the treatment of C. parapsilosis infections. Few studies have directly compared the efficacies of antifungal drugs for the treatment of C. parapsilosis infections. We hypothesize that different antifungal drugs offer differing clinical efficacy and safety for the treatment of C. parapsilosis infections. We performed a comprehensive network meta- analysis on different strategies for C. parapsilosis infection treatment and compared the clinical efficacy and safety of antifungal drugs as interventions for C. parapsilosis infections. The Cochrane Database of Systematic Reviews, Medline, Embase, PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Technology of Chongqing VIP database, Wan Fang Data, and SinoMed databases were searched to identify appropriate randomized trials. Among the extracted C. parapsilosis cases, the survival and death rates with treatment of C. parapsilosis infection were compared among groups treated with different antifungal drugs. According to the evidence- network analysis, echinocandins were a better choice than other drugs for treating C. parapsilosis infections, and more importantly, caspofungin showed a more preferable effect for decreasing the risk of 30 day mortality. In conclusion, this study systematically evaluated the effectiveness and safety of antifungal drugs for the purpose of helping clinicians choose the most appropriate antifungal drugs. Future studies with larger samples are needed to evaluate the effects of patient factors on the clinical efficacy and safety of antifungal drugs for C. parapsilosis infections.

引用

页数：8

共 34 条

[1] Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections:: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003 [J].